Inflammatory liver disease shortens atracurium-induced neuromuscular blockade in rats

European Journal of Anaesthesiology

Volumn 18, Issue 9, 2001, Pages 599-604

  Mayer, B ^a   Fink, H ^a   Bogdanski, R ^a   Stadler, J ^a,b   Blobner, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Kreiskrankenhaus Prien   (Germany)

Author keywords

Anesthesia and Analgesia, neuromuscular blockade; Digestive System, liver; Free Radical Scavengers, nitric oxide; Neuromuscular Non Depolarizing Agents, atracurium; Neurotransmitters, nitric oxide; Pathological Processes, inflammation; Rats

Indexed keywords

AMINOPHENAZONE; ATRACURIUM; CHOLINERGIC RECEPTOR; NITRATE; NITRIC OXIDE; NITRITE; PROPOFOL; PROTEIN;

ANESTHESIA INDUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BREATH ANALYSIS; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SENSITIVITY; GENDER; HEAT TREATMENT; HEPATITIS; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; MECHANOMYOGRAPHY; MUSCLE CONTRACTION; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NONHUMAN; PROPIONIBACTERIUM ACNES; RAT; RAT STRAIN; RECEPTOR UPREGULATION; SEPSIS;

ALANINE TRANSAMINASE; AMINOPYRINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATRACURIUM; BLOOD CELL COUNT; BREATH TESTS; CORYNEBACTERIUM INFECTIONS; HEMODYNAMIC PROCESSES; HEPATITIS; MALE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROPIONIBACTERIUM ACNES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035740791     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2346.2001.00897.x     Document Type: Article

References (18)

1. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit
2. Use of neuromuscular blocking drugs in intensive care unit patients
3. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients
4. Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: Treatment with N(G)-monomethyl-L-arginine
5. Resistance to atracurium in rats with experimental inflammation: Role of protein binding
6. Intraperitoneal endotoxin but not protein malnutrition shifts d-tubocurarine dose-response curves in mouse gastrocnemius muscle
7. Verminderte wirksamkeit von atracurium bei patienten mit intrathorakalem eiterherd
8. Atracurium infusions in patients with fulminant hepatic failure awaiting liver transplantation
9. Inhibition of nitric oxide synthases improves detoxication in inflammatory liver dysfunction in vivo
10. Pharmacodynamics of atracurium and vecuronium in rats with inflammatory liver dysfunction - Treatment with N-monomethyl-L-arginine
11. Measurement of nitric oxide in biological models
12. Suxamethonium-induced hyperkalaemia in patients with severe intra-abdominal infections
13. Sepsis attenuates the intensity of the neuromuscular blocking effect of d-tubocurarine and the antagonistic actions of neostigmine and edrophonium accompanying depression of muscle contractility of the diaphragm
14. Vecuronium infusion requirements in paediatric patients in intensive care units: The use of acceleromyography
15. Dose requirements of atracurium in paediatric intensive care patients
16. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit
17. The pharmacology of atracurium: A new competitive neuromuscular blocking agent
18. Up-and-down regulation of sceletal muscle acetylcholine receptors